Mogamulizumab, an Anti-CCR4 Antibody, Targets Human T-Lymphotropic Virus Type 1-infected CD8+ and CD4+ T Cells to Treat Associated Myelopathy

✍ Scribed by Yamauchi, J.; Coler-Reilly, A.; Sato, T.; Araya, N.; Yagishita, N.; Ando, H.; Kunitomo, Y.; Takahashi, K.; Tanaka, Y.; Shibagaki, Y.; Nishioka, K.; Nakajima, T.; Hasegawa, Y.; Utsunomiya, A.; Kimura, K.; Yamano, Y.

• Book ID: 127102210
• Publisher: University of Chicago Press
• Year: 2014
• Tongue: English
• Weight: 764 KB
• Volume: 211
• Category: Article
• ISSN: 0022-1899
• DOI: 10.1093/infdis/jiu438